Biden Will Attend Two Campaign Fundraisers in New York Wednesday
President Joe Biden will attend a New York campaign fundraiser hosted by food security expert Amy Goldman Fowler
1970-01-01 08:00
Berlusconi Office Backing $100 Million Pharma Startup Qualifyze
Qualifyze is closing in on a fundraising that could value the pharmaceutical compliance data firm at about $100
1970-01-01 08:00
Weight-Loss Drugs Cost Far More in US Than Other Nations
Sticker shock isn’t slowing Americans’ fervor for weight-loss drugs as a new analysis finds the drugs can cost
1970-01-01 08:00
Sanofi Was Mystery Bidder That Lost Reata to Biogen
Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to
1970-01-01 08:00
Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts
Moderna Inc. raised its Covid-19 vaccine sales outlook for the year, finalizing contracts with Japan and several American
1970-01-01 08:00
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
1970-01-01 08:00
Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
1970-01-01 08:00
Amazon, Apple Earnings to Provide Look at Consumer Habits
Consumer habits will come to the fore again in this week’s earnings deluge, as Amazon.com Inc., Shopify Inc.
1970-01-01 08:00
FDIC Seeks Buyers for $18.5 Billion of Signature Bank Loans Tied to Private Equity
The Federal Deposit Insurance Corp. launched the sale of an $18.5 billion loan portfolio from Signature Bank this
1970-01-01 08:00
White House Asks Walgreens, CVS, Walmart for Help Promoting Drug-Cost Law
Biden administration officials asked executives from major drug and retail chains to counter stiff opposition from the pharmaceutical
1970-01-01 08:00
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
1970-01-01 08:00
Japan Unveils $6 Billion Deal to Buy Out Chip Linchpin JSR
Japan’s government unveiled a $6.3 billion deal to buy out and privatize JSR Corp., taking direct control of
1970-01-01 08:00